Xsensio Revenue and Competitors

Lausanne,

Location

N/A

Total Funding

Technology

Industry

Estimated Revenue & Valuation

  • Xsensio's estimated annual revenue is currently $1.9M per year.(i)
  • Xsensio's estimated revenue per employee is $121,200

Employee Data

  • Xsensio has 16 Employees.(i)
  • Xsensio grew their employee count by 0% last year.

Xsensio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$45.3M2041%N/AN/A
#2
$54.3M250-20%N/AN/A
#3
$108.6M76818%N/AN/A
#4
$8.8M877%N/AN/A
#5
$15.9M1433%N/AN/A
#6
$10.2M1017%N/AN/A
#7
$3.2M405%N/AN/A
#8
$15.8M1428%N/AN/A
#9
$19.2M956%$125.1MN/A
#10
$21.6M1078%N/AN/A
Add Company

What Is Xsensio?

Xsensio develops the unique Lab-on-Skinâ„¢ sensing platform for next-gen wearables. It senses in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. Xsensio is a B2B company, offering Lab-on-Skinâ„¢ solutions to consumer care and consumer electronics companies.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Xsensio News

2022-04-17 - Biosensors Market Overwhelming Hike In Near Future With ...

KGaA, Ercon Inc., Xsensio, Analog Devices, Inc., Animas LLC, LifeSensors, Siemens, F. Hoffmann-La Roche Ltd, i-SENS, Inc., TaiDoc Technology...

2022-03-30 - Global Electronic Skin Market worth $16 Billion by 2026

Byteflies & Quad Industries, Xenoma Inc., Abbott Laboratories, Xsensio, Bloomlife, VivaLnK, Inc., and iRhythm among many others are some of...

2022-03-22 - Third Cohort of Mayo Clinic and Arizona State University MedTech Accelerator Commences

Xsensio, Switzerland: Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real time biochemical information at the surface...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M160%N/A
#2
$1.4M16-27%N/A
#3
$1.4M16N/AN/A
#4
$3.3M170%N/A
#5
$2.6M176%N/A